Your browser doesn't support javascript.
loading
Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer.
Falandry, C; Canney, P A; Freyer, G; Dirix, L Y.
Affiliation
  • Falandry C; Department of Medical Oncology, Centre Hospitalier Lyon Sud, Pierre-Bénite, France. claire.leger-falandry@ens-lyon.fr
Ann Oncol ; 20(4): 615-20, 2009 Apr.
Article in En | MEDLINE | ID: mdl-19254941
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Cyclooxygenase Inhibitors / Aromatase Inhibitors Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2009 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Cyclooxygenase Inhibitors / Aromatase Inhibitors Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2009 Document type: Article Affiliation country: